The global Charcot-Marie-Tooth disease treatment market is projected to experience significant expansion in the coming years, driven by factors such as an growing prevalence of the illness, advancements in therapy, and growing healthcare spending. The market is segmented by type of treatment, indication, pharmacy network, and geography. Key players